INS and Large for gestational age: Mesdaghinia et al. reported a lower prevalence of macrosomia in metformin-treated mothers than insulin-treated mothers, and the prevalences of LGA, neonatal hyperbilirubinemia, RDS, and anomalies tended to be lower in the metformin group, although significant differences were not identified [55].